LUNG CANCER STAGE IV

Clinical trials for LUNG CANCER STAGE IV explained in plain language.

Never miss a new study

Get alerted when new LUNG CANCER STAGE IV trials appear

Sign up with your email to follow new studies for LUNG CANCER STAGE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Terminated 1

New pill plus immunotherapy shows promise for tough lung cancer

Disease control Terminated

This study tested a new pill (SLC-391) combined with an immunotherapy drug (pembrolizumab) in people with advanced non-small cell lung cancer. The goal was to find a safe dose and see if the combo could shrink tumors or stop them from growing. The trial was stopped early, but res…

Matched conditions: LUNG CANCER STAGE IV

Phase: PHASE1, PHASE2 • Sponsor: SignalChem Lifesciences Corporation • Aim: Disease control

Last updated May 12, 2026 13:41 UTC

LUNG CANCER STAGE IV

Get alerted when new LUNG CANCER STAGE IV trials appear

New pill plus immunotherapy shows promise for tough lung cancer